Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Novo Nordisk A/S Sponsored ADR Class B
Telephone
45.44.44.88.88
Address
Novo Allé 1, Bagsværd, Capital Region 2880
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 35.09 - 82.09
Trade Value (12mth)
US$3,140,890.00
1 week
-4.18%
1 month
9.82%
YTD
-12.77%
1 year
-35.26%
All time high
149.80
EPS 3 yr Growth
101.40%
EBITDA Margin
48.40%
Operating Cashflow
$18,010m
Free Cash Flow Return
44.10%
ROIC
38.00%
Interest Coverage
35.40
Quick Ratio
0.60
Shares Outstanding (Fully Diluted)
4,449m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
30-Mar-26
Next Dividend Pay Date
08-Apr-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | 2.71 | 3.29 | 3.49 | | | | ||
EPS (Fully Diluted) | GBP | | | | | 2.7 | 3.28 | 3.48 | | | | ||
Growth | % | | | | | 56.4 | 21.4 | 6 | | | | ||
PE | X | | | | | 38.2 | 26.2 | 14.6 | | | | ||
EV/EBITDA | X | | | | | 28.7 | 18.4 | 10.7 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
